Product NDC: | 51991-650 |
Proprietary Name: | Levetiracetam |
Non Proprietary Name: | Levetiracetam |
Active Ingredient(s): | 1000 mg/1 & nbsp; Levetiracetam |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51991-650 |
Labeler Name: | Breckenridge Pharmaceutical, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090511 |
Marketing Category: | ANDA |
Start Marketing Date: | 20111101 |
Package NDC: | 51991-650-06 |
Package Description: | 60 TABLET in 1 BOTTLE (51991-650-06) |
NDC Code | 51991-650-06 |
Proprietary Name | Levetiracetam |
Package Description | 60 TABLET in 1 BOTTLE (51991-650-06) |
Product NDC | 51991-650 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Levetiracetam |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20111101 |
Marketing Category Name | ANDA |
Labeler Name | Breckenridge Pharmaceutical, Inc. |
Substance Name | LEVETIRACETAM |
Strength Number | 1000 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |